High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.

Polley, SD; Conway, DJ; Cavanagh, DR; McBride, JS; Lowe, BS; Williams, TN; Mwangi, TW; Marsh, K; (2006) High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine, 24 (19). pp. 4233-46. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2005.06.030

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2005.06.030

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar